Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.285
-0.030-0.56%
Volume:64.00K
Turnover:338.62K
Market Cap:4.31B
PE:-22.65
High:5.340
Open:5.320
Low:5.270
Close:5.315
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.18
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:1.00
PE(LYR):-22.65
PS:4.59

Loading ...

TYK MEDICINES-B Initiates Legal Proceedings Against Sichuan Huiyu Pharmaceutical Co., Ltd.

Stock News
·
Jul 22

Prospective IPO: Unique Dual-Target and Global First-in-Class Candidate, Can Highlights Pharmaceutical Craft a New Narrative in a Crowded Field?

Stock News
·
Jul 22

Bonsun Pharmaceuticals' Hong Kong IPO Prospectus Lapses

Stock News
·
Jul 22

Portfolio Adjustments Revealed in Fidelity's Zhu Shaoxing Managed Fund Q2 Report

Stock News
·
Jul 21

Novartis Q2 Results Exceed Expectations as Strong Sales of Innovative Drugs Offset Generic Competition, Signaling Return to Growth

Stock News
·
Jul 21

Hong Kong Connect Innovative Drug Stocks Plunge Amid Market Turmoil, 520880 ETF Sees Heavy Volume and Premium; A-Share Pharmaceutical Sector Shows Resilience, Only On-Market Pharma ETF Ends Week in the Green

Deep News
·
Jul 19

Investors Mistake One Company for Another, Sending Shares Soaring 183% in Two Weeks; Firm Issues Clarification

Deep News
·
Jul 19

PegBio, Tengrui Pharma, and Ali Health Forge Strategic Alliance to Accelerate Commercialization and Market Expansion of Patacon

Stock News
·
Jul 17

ASCLETIS Executes Share Buyback, Spending HK$2.58 Million on July 17

Stock News
·
Jul 17

Pre-IPO Analysis | High R&D Investment Meets Cash Flow Test, Mingyu Pharmaceutical's IPO Faces a Crucial Battle

Stock News
·
Jul 16

AI-Powered Drug Development Accelerates Commercialization with Major Partnerships and Industry Giants Entering the Field (Related Stocks Listed)

Stock News
·
Jul 16

ASCLETIS-B Chooses Fixed-Dose Combination of Pioneering Oral Small Molecule GIPR Agonist ASC48 and Oral GLP-1R Agonist ASC30 for Clinical Development

Stock News
·
Jul 15

Mingyu Pharma, Led by Hengrui Veteran, Files for Hong Kong IPO Amid Fierce Market Competition

Deep News
·
Jul 15

ASCLETIS-B (01672) Allocates HK$2.09 Million for Share Buyback on July 14

Stock News
·
Jul 14

Morgan Stanley Adjusts Earnings Per Share Forecasts for SBP GROUP Through 2028, Reiterates 'Overweight' Rating

Stock News
·
Jul 14

Pre-IPO Outlook: With the World's First Fourth-Generation BTK Inhibitor, Can Lupeng Pharmaceutical Unlock a Multi-Billion Dollar Market?

Stock News
·
Jul 13

Warburg Pincus in Advanced Talks for $7B+ Acquisition of Rare Disease Pharma Pantherx with ADIA

Deep News
·
Jul 12

ASCLETIS-B Executes Share Buyback, Spending HK$1.119 Million

Stock News
·
Jul 08

ASCLETIS-B Executes Share Buyback on July 7, Spending HK$1.153 Million

Stock News
·
Jul 07

Fresh Legal Filings Submitted for Investor Claims Against Zitian Tech and Poly Pharm

Deep News
·
Jul 06